Cancer Incidence and Mortality among Non-Hispanic Whites, New York City, 2011-2015

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 18043.0 510.6 507.2-514.1 8700.0 541.8 536.6-547.0 9343.0 497.2 492.4-502.0 5639.4 147.1 145.3-148.9 2736.0 168.6 165.8-171.5 2903.4 132.6 130.3-134.9
Oral cavity and pharynx 363.2 10.3 9.8-10.8 243.2 15.0 14.2-15.9 120.0 6.2 5.7-6.8 73.2 2.0 1.8-2.2 50.8 3.1 2.7-3.5 22.4 1.1 0.9-1.3
Esophagus 138.0 3.8 3.5-4.1 99.6 6.2 5.7-6.8 38.4 1.8 1.5-2.1 113.0 3.0 2.8-3.3 78.4 4.9 4.4-5.4 34.6 1.5 1.3-1.8
Stomach 303.0 8.2 7.8-8.6 177.8 11.1 10.3-11.8 125.2 5.9 5.4-6.4 145.2 3.7 3.5-4.0 79.8 4.9 4.5-5.4 65.4 2.8 2.5-3.2
Colorectal 1513.6 41.6 40.6-42.6 762.0 47.7 46.2-49.3 751.6 36.8 35.5-38.0 542.6 13.9 13.3-14.4 260.0 16.1 15.2-17.0 282.6 12.2 11.5-12.9
Colon excluding rectum 1093.4 29.6 28.8-30.5 534.4 33.5 32.2-34.8 559.0 26.7 25.6-27.8 455.6 11.5 11.0-12.0 216.2 13.3 12.5-14.2 239.4 10.2 9.6-10.8
Rectum & rectosigmoid 420.2 12.0 11.5-12.5 227.6 14.3 13.4-15.1 192.6 10.1 9.4-10.8 87.0 2.3 2.1-2.6 43.8 2.7 2.4-3.1 43.2 2.0 1.7-2.3
Liver / intrahepatic bile duct 277.4 7.6 7.2-8.0 189.6 11.4 10.7-12.2 87.8 4.2 3.8-4.7 194.0 5.1 4.8-5.4 127.4 7.7 7.1-8.3 66.6 3.0 2.6-3.3
Pancreas 570.6 15.1 14.6-15.7 288.0 17.8 16.9-18.8 282.6 13.0 12.3-13.7 446.8 11.5 11.0-12.0 223.4 13.7 12.9-14.5 223.4 9.7 9.1-10.4
Larynx 115.4 3.2 2.9-3.5 94.0 5.7 5.2-6.3 21.4 1.1 0.9-1.3 32.2 0.9 0.7-1.0 24.8 1.5 1.3-1.8 7.4 0.4 0.2-0.5
Lung and bronchus 2151.8 58.1 57.0-59.2 1048.4 64.6 62.8-66.4 1103.4 53.6 52.2-55.1 1333.2 35.1 34.2-35.9 687.6 42.3 40.8-43.7 645.6 29.8 28.7-30.9
Melanoma of the skin 803.0 23.0 22.3-23.8 444.2 28.0 26.8-29.2 358.8 19.6 18.6-20.6 85.2 2.3 2.1-2.5 51.2 3.2 2.8-3.6 34.0 1.6 1.3-1.9
Female breast             2585.2 145.9 143.3-148.6             444.0 21.1 20.2-22.1
Cervix uteri             113.0 7.0 6.4-7.7             37.8 2.0 1.8-2.4
Corpus uterus and NOS             648.4 34.4 33.2-35.7             119.0 5.7 5.2-6.2
Ovary             275.6 15.0 14.2-15.9             173.2 8.4 7.8-9.0
Prostate       1869.8 112.0 109.7-114.3             256.6 15.6 14.7-16.5      
Testis       123.0 8.3 7.6-9.0             3.0 0.2 0.1-0.3      
Urinary bladder (incl. in situ) 952.2 25.3 24.6-26.1 714.8 44.3 42.8-45.8 237.4 11.0 10.4-11.7 192.8 4.7 4.4-5.0 133.2 8.1 7.5-8.7 59.6 2.3 2.1-2.6
Kidney and renal pelvis 583.6 16.9 16.2-17.5 380.6 23.8 22.8-25.0 203.0 10.8 10.1-11.5 118.6 3.1 2.9-3.4 73.4 4.5 4.1-5.0 45.2 2.0 1.7-2.3
Brain and other nervous system 254.0 8.0 7.5-8.5 134.2 9.1 8.4-9.8 119.8 7.0 6.4-7.6 148.6 4.3 4.0-4.6 74.8 4.8 4.3-5.3 73.8 3.8 3.4-4.2
Thyroid 839.8 27.5 26.6-28.3 230.0 15.3 14.4-16.2 609.8 39.7 38.2-41.2 22.8 0.6 0.5-0.7 9.4 0.6 0.4-0.8 13.4 0.6 0.4-0.7
Hodgkin lymphoma 116.4 4.1 3.7-4.4 60.8 4.3 3.8-4.9 55.6 3.8 3.4-4.3 16.0 0.5 0.4-0.6 8.0 0.5 0.4-0.7 8.0 0.4 0.3-0.6
Non-Hodgkin lymphomas 879.2 25.2 24.4-26.0 474.0 30.5 29.2-31.7 405.2 20.7 19.8-21.7 213.4 5.4 5.1-5.8 113.8 7.1 6.5-7.7 99.6 4.2 3.8-4.6
Myeloma 268.0 7.3 6.9-7.7 156.4 9.7 9.0-10.4 111.6 5.4 5.0-5.9 91.2 2.4 2.1-2.6 47.2 2.9 2.6-3.3 44.0 1.9 1.7-2.2
Leukemias 642.4 18.2 17.5-18.9 363.8 23.3 22.2-24.4 278.6 14.3 13.5-15.1 247.4 6.5 6.1-6.9 139.2 8.8 8.1-9.5 108.2 4.9 4.4-5.3

Notes

  • Incidence data are provisional, November 2017.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.